Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial

Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T18:42:03.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed information about a clinical study for the drug obeldesivir (GS-5245) related to COVID-19, and the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    9%
    Check dated 2025-04-16T13:16:10.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 20, 2024.
    Difference
    0.7%
    Check dated 2025-04-09T06:50:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has updated its versioning information, moving from Revision v2.14.2 to v2.14.3, and has changed the last update date from December 20, 2024, to March 25, 2025.
    Difference
    0.5%
    Check dated 2025-04-01T22:59:26.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:32:40.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:39:41.000Z thumbnail image

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.